269 related articles for article (PubMed ID: 18048022)
1. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.
Tang WH; Francis GS; Morrow DA; Newby LK; Cannon CP; Jesse RL; Storrow AB; Christenson RH;
Clin Biochem; 2008 Mar; 41(4-5):210-21. PubMed ID: 18048022
[No Abstract] [Full Text] [Related]
2. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.
Tang WH; Francis GS; Morrow DA; Newby LK; Cannon CP; Jesse RL; Storrow AB; Christenson RH; Apple FS; Ravkilde J; Wu AH;
Circulation; 2007 Jul; 116(5):e99-109. PubMed ID: 17630410
[No Abstract] [Full Text] [Related]
3. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure.
Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; ;
Clin Biochem; 2008 Mar; 41(4-5):222-6. PubMed ID: 18035345
[No Abstract] [Full Text] [Related]
4. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.
Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; Cannon CP; Francis G; Jesse RL; Morrow DA; Newby LK; Storrow AB; Tang WH; Pagani F; Tate J; Ordonez-Llanos J; Mair J; ;
Circulation; 2007 Jul; 116(5):e95-8. PubMed ID: 17630411
[No Abstract] [Full Text] [Related]
5. Plasma NT-proBNP: a new biomarker for diagnosis and monitoring of congestive heart failure (CHF).
Bayes-Genis A
Timely Top Med Cardiovasc Dis; 2006 Apr; 10():E10. PubMed ID: 17066132
[No Abstract] [Full Text] [Related]
6. [NT-proBNP in practice: from chemistry to medicine].
Jourdain P; Lefèvre G; Oddoze C; Sapin V; Dievart F; Jondeau G; Meune C; Galinier M
Ann Cardiol Angeiol (Paris); 2009 Jun; 58(3):165-79. PubMed ID: 19457468
[TBL] [Abstract][Full Text] [Related]
7. Amino-terminal pro-brain natriuretic peptide to diagnose congestive heart failure in patients with impaired kidney function.
Lamb EJ; Vickery S; Price CP
J Am Coll Cardiol; 2006 Sep; 48(5):1060-1; author reply 1061. PubMed ID: 16949506
[No Abstract] [Full Text] [Related]
8. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.
Januzzi JL; Bayes-Genis A
Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464
[TBL] [Abstract][Full Text] [Related]
9. [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].
Dahlström U; Alehagen U
Lakartidningen; 2006 Mar 22-28; 103(12):927-9. PubMed ID: 16618036
[No Abstract] [Full Text] [Related]
10. Natriuretic peptides: putting the evidence into practice.
Andrade A; Sharar H
Can J Cardiovasc Nurs; 2008; 18(4):34-9. PubMed ID: 19093420
[TBL] [Abstract][Full Text] [Related]
11. Response to "Getting the right message".
Januzzi JL; Camargo CA; Tung R
Ann Emerg Med; 2007 Mar; 49(3):381-3; discussion 383; author reply 384. PubMed ID: 17317512
[No Abstract] [Full Text] [Related]
12. [Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure].
Lindstedt G
Lakartidningen; 2006 Mar 22-28; 103(12):930-2, 934-7. PubMed ID: 16618037
[No Abstract] [Full Text] [Related]
13. Biomarker screening for cardiac dysfunction: the more the merrier?
Tang WH
Am Heart J; 2006 Jul; 152(1):1-3. PubMed ID: 16824825
[No Abstract] [Full Text] [Related]
14. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
[TBL] [Abstract][Full Text] [Related]
15. Improving risk stratification for heart failure. A role for serial testing of B-type natriuretic peptides?
Daly MG; Frampton CM; Troughton RW
J Am Coll Cardiol; 2010 Feb; 55(5):451-3. PubMed ID: 20117458
[No Abstract] [Full Text] [Related]
16. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
Green SM; Green JA; Januzzi JL
Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
[TBL] [Abstract][Full Text] [Related]
17. [Cut-off values of BNP and NT-BNP for diagnosis of heart failure in emergency service].
Akpinar O; Kanadaşi M; Ilgenli TF
Anadolu Kardiyol Derg; 2006 Dec; 6(4):395-6. PubMed ID: 17162299
[No Abstract] [Full Text] [Related]
18. Diagnosing acute heart failure: the mathematician and the clinician.
Dickstein K
J Am Coll Cardiol; 2009 Oct; 54(16):1522-3. PubMed ID: 19815123
[No Abstract] [Full Text] [Related]
19. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
[TBL] [Abstract][Full Text] [Related]
20. When renal and cardiac insufficiencies intersect: is there a role for natriuretic peptide testing in the 'cardio-renal syndrome'?
van Kimmenade RR; Pinto Y; Januzzi JL
Eur Heart J; 2007 Dec; 28(24):2960-1. PubMed ID: 17984131
[No Abstract] [Full Text] [Related]
[Next] [New Search]
